PRMT5 and liver cancer: PRMT5 knockdown inhibits proliferation and cell cycle transition from the G1 to S phase, and a large number of corroborating studies have shown that PRMT5 levels are elevated in various cancers, including gastric, colorectal, lung, lymphoma, leukemia, and liver cancers 5, 8, 9, 10, 11.